From: Placental fibroblast growth factor 21 is not altered in late-onset preeclampsia
Control | PE | P-value | |
---|---|---|---|
N | 20 | 17 | |
Age (years) | 32.8 ± 5.3 | 30.2 ± 6.7 | 0.25 |
Pre-pregnancy BMI (kg/m2) | 24.9 ± 4.9 | 25.2 ± 5.5 | 0.87 |
Gravidity (median, IQR) | 2.5 (2–4) | 2 (1–4) | ND |
Parity (median, IQR) | 1 (1–2) | 0 (0–1) | ND |
Ethniticy (Caucasian/other) | 18/2 | 17/0 | ND |
SBP (T3) mmHg | 118 ± 13 | 135 ± 18* | 0.003 |
DBP (T3) mmHg | 73 ± 9 | 84 ± 15* | 0.01 |
SBP (early preg) mmHg | 107 ± 8 | 115 ± 14 | 0.08 |
DBP (early preg) mmHg | 65 ± 8 | 67 ± 10 | 0.40 |
Mode of delivery (VD/CS) | 0/20 | 10/7 | <0.0001 |
GA delivery (d) | 269.6 ± 8.3 | 268.1 ± 10.3 | 0.64 |
Birth weight (g) | 3279 ± 623 | 3150 ± 673 | 0.55 |
Baby gender (M/F) | 10/10 | 9/8 | ND |
Glucose screen result (mmol/L) | 5.76 ± 1.02 | 6.10 ± 1.46 | 0.51 |